TalkTop 科技圈顶流在说什么
原话 生物医药与基因·

最年轻结直肠癌患者生存可能不如年长者

他们的生存情况,尤其是35岁以下最年轻患者,实际上可能不如40多岁或60多岁的人,尽管他们接受了更积极的治疗,且基线时更健康。

English original

Their survival, especially for the very youngest patients under the age of 35, may actually not be as good as somebody in their 40s or someone in their 60s, despite receiving more aggressive treatment and being at baseline healthier.

单细胞图谱新研究

K
Kimmie NgDana-Farber Cancer Institute · colorectal cancer researcher and director of the Young-Onset Colorectal Cancer Center

原始出处

statnews.com · 2026-10-29

同主题言论: 生物医药与基因

更多 →